Related Experiment Video
Updated: May 7, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.0K
The current challenges to efficient immature oocyte cryopreservation
Fausta Brambillasca1, Maria Cristina Guglielmo, Giovanni Coticchio
1Biogenesi Reproductive Medicine Centre, Istituti Clinici Zucchi, Via Zucchi, 24, 20900, Monza, Italy.
Journal of Assisted Reproduction and Genetics
|October 12, 2013
Summary
Oocyte cryopreservation and in vitro maturation are key assisted reproductive technologies. This review examines the combined use and cryopreservation of immature or in vitro matured oocytes, focusing on biological implications.
Area of Science:
- Reproductive Biology
- Assisted Reproductive Technology
- Cryobiology
Background:
- Oocyte cryopreservation preserves fertility for women facing ovarian function loss and offers alternatives for couples with embryo cryopreservation constraints.
- In vitro oocyte maturation aids patients with contraindications for ovarian stimulation, including cancer patients and those at risk of ovarian hyperstimulation syndrome.
Purpose of the Study:
- To review the combination of oocyte in vitro maturation and cryopreservation.
- To emphasize the biological implications of cryopreserving immature or in vitro matured oocytes.
Main Methods:
- Discussion of slow freezing and vitrification techniques for oocyte cryopreservation.
- Analysis of potential cryodamage to oocyte subcellular structures.
- Examination of the functional interaction between oocytes and cumulus cells post-cryopreservation.
Main Results:
- While mature oocyte cryopreservation is established, data on immature or in vitro matured oocyte cryopreservation efficiency is limited.
- Cryopreservation methods (slow freezing vs. vitrification) may impact oocyte viability and function.
- The interaction between oocytes and cumulus cells is a critical factor in successful cryopreservation outcomes.
Conclusions:
- Combining in vitro oocyte maturation with cryopreservation presents unique challenges and requires further investigation.
- Understanding the biological impact of cryopreservation on immature and in vitro matured oocytes is crucial for optimizing fertility preservation strategies.
- Future research should focus on improving cryopreservation protocols for immature and in vitro matured oocytes to enhance their viability and developmental potential.
Related Concept Videos
Oogenesis
58.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.5K
Meiosis II
169.5K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
169.5K

